Management of lymphatic malformations

Clinics in Plastic Surgery

Volumn 38, Issue 1, 2011, Pages 75-82

  Greene, Arin K ^a   Perlyn, Chad A ^b   Alomari, Ahmad I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Lymphatic malformation; Sclerotherapy; Treatment; Vascular anomaly; Vascular malformation

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; BLEOMYCIN; DOXYCYCLINE; PICIBANIL; TETRADECYL SULFATE SODIUM;

ANAMNESIS; BLEEDING; CENTRAL NERVOUS SYSTEM DEPRESSION; CLINICAL FEATURE; COMPRESSION GARMENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; HEART ARRHYTHMIA; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; INFECTION; LIPOSUCTION; LYMPHADENECTOMY; LYMPHATIC MALFORMATION; LYMPHATIC SYSTEM DISEASE; LYMPHEDEMA; NERVE INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PULMONARY HYPERTENSION; REVIEW; SCLEROTHERAPY; SEPSIS; SIDE EFFECT; SKIN ULCER; SYSTEMIC DISEASE; THERAPY EFFECT; THROMBOEMBOLISM; TRACHEOSTOMY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LYMPHATIC ABNORMALITIES;

EID: 78649274510     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2010.08.006     Document Type: Review

References (40)

1. Young A.E. Pathogenesis of vascular malformations. Vascular birthmarks: hemangiomas and malformations 1988, 107-113. Saunders, Philadelphia (PA). J.B. Mulliken, A.E. Young (Eds.).
2. Mulliken J.B., Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982, 69:412-422.
3. Finn M.C., Glowacki J., Mulliken J.B. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983, 18:894-900.
4. Sabin F. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am J Anat 1902, 1:367-389.
5. Kaipainen A., Korhonen J., Mustonen T., et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 1995, 92:3566-3570.
6. Wigle J.T., Oliver G. Prox 1 function is required for the development of the murine lymphatic system. Cell 1999, 98:769-778.
7. Smeltzer D.M., Stickler G.B., Schirger A. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics 1985, 76:206-218.
8. Limaye N., Boon L.M., Vikkula M. From germline towards somatic mutations in the pathophysiology of vascular anomalies. Hum Mol Genet 2009, 18:65-75.
9. Padwa B.L., Hayward P.G., Ferraro N.F., et al. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg 1995, 95:951-960.
10. Edwards P.D., Rahbar R., Ferraro N.F., et al. Lymphatic malformation of the lingual base and oral floor. Plast Reconstr Surg 2005, 115:1906-1915.
11. Greene A.K., Burrows P.E., Smith L., et al. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg 2005, 115:22-30.
12. Upton J., Coombs C.J., Mulliken J.B., et al. Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg Am 1999, 24:1019-1035.
13. Choi D.J., Alomari A.I., Chaudry G., et al. Neurointerventional management of low-flow vascular malformations of the head and neck. Neuroimaging Clin N Am 2009, 19:199-218.
14. Burrows R.E., Laor T., Paltiel H., et al. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 1998, 16:455-488.
15. Paltiel H., Burrows P.E., Kozakewich H.P., et al. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 2000, 214:747-754.
16. Florez-Vargas A., Vargas S.O., Debelenko L.V., et al. Comparative analysis of D2-40 and LYVE-1 immunostaining in lymphatic malformations. Lymphology 2008, 41:103-110.
17. Tiret L., Nivoche Y., Hatton F., et al. Complications related to anesthesia in infants and children. Br J Anaesth 1988, 61:263-269.
18. Cohen M.M., Cameron C.B., Duncan P.G. Pediatric anesthesia morbidity and mortality in the perioperative period. Anesth Analg 1990, 70:160-167.
19. Tay C.L., Tan G.M., Ng S.A. Critical incidents in paediatric anaesthesia: an audit of 1000 anaesthetics in Singapore. Paediatr Anaesth 2001, 11:711-718.
20. Murat I., Constant I., Maudhuy H. Perioperative anaesthetic morbidity in children: database of 24,165 anaesthetics over a 30-month period. Paediatr Anaesth 2004, 14:158-166.
21. Charlesworth R. The toddler: affective development. Charlesworth R, editor. Understanding child development 1994, 304. Delmar Learning. 6th edition. Clifton Park (NY):.
22. Santrock J.W. The self and identity. Santrock JW, editor. Child development 1996, 378-385. McGraw-Hill. 7th edition. Columbus (OH):.
23. Neisser U. Memory development: new questions and old. Developmental Review 2004, 24:154.
24. Smith M.C., Zimmerman B., Burke D.K., et al. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 2009, 119:107-115.
25. Burrows P.E., Mitri R.K., Alomari A., et al. Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 2008, 6:209-216.
26. Nehra D., Jacobson L., Barnes P., et al. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg 2008, 43:451-460.
27. Alomari A.I., Karian V.E., Lord D.J., et al. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 2006, 17:1639-1648.
28. Burrows P.E., Mason K.P. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004, 15:431-445.
29. Bai Y., Jia J., Huang X.X., et al. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg 2009, 67:251-256.
30. Berenguer B., Burrows P.E., Zurakowski D., et al. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999, 104:1-11.
31. Alqahtani A., Nguyen L.T., Flageole H., et al. 25 years' experience with lymphangiomas in children. J Pediatr Surg 1999, 34:1164-1168.
32. Saijo M., Munro I.R., Mancer K. Lymphangioma. A long-term follow-up study. Plast Reconstr Surg 1975, 56:642-651.
33. Fliegelman L.J., Friedland D., Brandwein M., et al. Lymphatic malformation: predictive factors for recurrence. Otolaryngol Head Neck Surg 2000, 123:706-710.
34. Brorson H., Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg 1998, 102:1058-1067.
35. Greene A.K., Slavin S.A., Borud L. Treatment of lower extremity lymphedema with suction-assisted lipectomy. Plast Reconstr Surg 2006, 118:118e-121e.
36. Miller T.A., Wyatt L.E., Rudkin G.H. Staged skin and subcutaneous excision for lymphedema: a favorable report of long-term results. Plast Reconstr Surg 1998, 102:1486-1498.
37. Grimmer J.F., Mulliken J.B., Burrows P.E., et al. Radiofrequency ablation of microcystic lymphatic malformation in the oral cavity. Arch Otolaryngol Head Neck Surg 2006, 132:1251-1256.
38. Wiegand S., Eivazi B., Zimmermann A.P., et al. Microcystic lymphatic malformations of the tongue: diagnosis, classification, and treatment. Arch Otolaryngol Head Neck Surg 2009, 135:976-983.
39. Boardman S.J., Cochrane L.A., Roebuck D., et al. Multimodality treatment of pediatric lymphatic malformations of the head and neck using surgery and sclerotherapy. Arch Otolaryngol Head Neck Surg 2010, 136:270-276.
40. Perkins J.A. Overview of macroglossia and its treatment. Curr Opin Otolaryngol Head Neck Surg 2009, 17:460-465.